1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted

2. Executive Summary
2.1. Market Snapshot: Global Genitourinary Drugs Market
2.2. Global Genitourinary Drugs Market, By Drug Type, 2023 (US$ Million)
2.3. Global Genitourinary Drugs Market, By Application, 2023 (US$ Million)
2.4. Global Genitourinary Drugs Market, By Route of Administration, 2023 (US$ Million)
2.5. Global Genitourinary Drugs Market, By Distribution Channel, 2023 (US$ Million)
2.6. Global Genitourinary Drugs Market, By Geography, 2023 (US$ Million)
2.7. Attractive Investment Proposition by Geography, 2023

3. Genitourinary Drugs Market: Competitive Analysis
3.1. Market Positioning of Key Genitourinary Drugs Market Vendors
3.2. Strategies Adopted by Genitourinary Drugs Market Vendors
3.3. Key Industry Strategies
4. Genitourinary Drugs Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Genitourinary Drugs Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat Of Substitutes
4.6.4. Threat Of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape

5. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Hormonal therapy
5.3.1.1. Androgen
5.3.1.2. Estrogen
5.3.1.3. Other hormonal therapy
5.3.2. Anti-infective
5.3.2.1. Antibiotics
5.3.2.2. Antifungals
5.3.2.3. Antivirals
5.3.3. Other drug types

6. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Urinary tract infections (UTIs)
6.3.2. Benign prostatic hyperplasia (BPH)
6.3.3. Prostate cancer
6.3.4. Overactive bladder
6.3.5. Bladder cancer
6.3.6. Other applications

7. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Oral
7.3.2. Parenteral
7.3.3. Topical

8. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Growth & Revenue Analysis: 2023 Versus 2032
8.3. Market Segmentation
8.3.1. Hospital pharmacies
8.3.2. Drug store & retail pharmacies
8.3.3. Online pharmacies


9. North America Genitourinary Drugs Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
9.3. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
9.4. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
9.5. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
9.6.Genitourinary Drugs Market: By Region, 2022-2032, USD (Million)
9.6.1.North America
9.6.1.1. U.S.
9.6.1.1.1. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
9.6.1.1.2. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
9.6.1.1.3. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
9.6.1.1.4. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
9.6.1.2. Canada
9.6.1.2.1. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
9.6.1.2.2. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
9.6.1.2.3. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
9.6.1.2.4. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
9.6.1.3. Rest of North America
9.6.1.3.1. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
9.6.1.3.2. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
9.6.1.3.3. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
9.6.1.3.4. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)

10. UK and European Union Genitourinary Drugs Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
10.3. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
10.4. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
10.5. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
10.6.Genitourinary Drugs Market: By Region, 2022-2032, USD (Million)
10.6.1.UK and European Union
10.6.1.1. UK
10.6.1.1.1. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
10.6.1.1.2. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
10.6.1.1.3. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
10.6.1.1.4. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
10.6.1.2. Germany
10.6.1.2.1. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
10.6.1.2.2. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
10.6.1.2.3. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
10.6.1.2.4. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
10.6.1.3. Spain
10.6.1.3.1. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
10.6.1.3.2. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
10.6.1.3.3. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
10.6.1.3.4. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
10.6.1.4. Italy
10.6.1.4.1. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
10.6.1.4.2. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
10.6.1.4.3. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
10.6.1.4.4. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
10.6.1.5. France
10.6.1.5.1. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
10.6.1.5.2. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
10.6.1.5.3. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
10.6.1.5.4. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
10.6.1.6. Rest of Europe
10.6.1.6.1. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
10.6.1.6.2. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
10.6.1.6.3. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
10.6.1.6.4. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)

11. Asia Pacific Genitourinary Drugs Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
11.3. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
11.4. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
11.5. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
11.6.Genitourinary Drugs Market: By Region, 2022-2032, USD (Million)
11.6.1.Asia Pacific
11.6.1.1. China
11.6.1.1.1. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
11.6.1.1.2. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
11.6.1.1.3. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
11.6.1.1.4. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
11.6.1.2. Japan
11.6.1.2.1. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
11.6.1.2.2. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
11.6.1.2.3. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
11.6.1.2.4. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
11.6.1.3. India
11.6.1.3.1. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
11.6.1.3.2. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
11.6.1.3.3. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
11.6.1.3.4. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
11.6.1.4. Australia
11.6.1.4.1. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
11.6.1.4.2. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
11.6.1.4.3. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
11.6.1.4.4. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
11.6.1.5. South Korea
11.6.1.5.1. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
11.6.1.5.2. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
11.6.1.5.3. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
11.6.1.5.4. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
11.6.1.6. Rest of Asia Pacific
11.6.1.6.1. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
11.6.1.6.2. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
11.6.1.6.3. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
11.6.1.6.4. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)

12. Latin America Genitourinary Drugs Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
12.3. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
12.4. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
12.5. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
12.6.Genitourinary Drugs Market: By Region, 2022-2032, USD (Million)
12.6.1.Latin America
12.6.1.1. Brazil
12.6.1.1.1. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
12.6.1.1.2. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
12.6.1.1.3. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
12.6.1.1.4. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
12.6.1.2. Mexico
12.6.1.2.1. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
12.6.1.2.2. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
12.6.1.2.3. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
12.6.1.2.4. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
12.6.1.3. Rest of Latin America
12.6.1.3.1. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
12.6.1.3.2. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
12.6.1.3.3. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
12.6.1.3.4. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)

13. Middle East and Africa Genitourinary Drugs Market, 2022-2032, USD (Million)
13.1. Market Overview
13.2. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
13.3. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
13.4. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
13.5. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
13.6.Genitourinary Drugs Market: By Region, 2022-2032, USD (Million)
13.6.1.Middle East and Africa
13.6.1.1. GCC
13.6.1.1.1. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
13.6.1.1.2. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
13.6.1.1.3. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
13.6.1.1.4. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
13.6.1.2. Africa
13.6.1.2.1. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
13.6.1.2.2. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
13.6.1.2.3. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
13.6.1.2.4. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
13.6.1.3. Rest of Middle East and Africa
13.6.1.3.1. Genitourinary Drugs Market: By Drug Type, 2022-2032, USD (Million)
13.6.1.3.2. Genitourinary Drugs Market: By Application, 2022-2032, USD (Million)
13.6.1.3.3. Genitourinary Drugs Market: By Route of Administration, 2022-2032, USD (Million)
13.6.1.3.4. Genitourinary Drugs Market: By Distribution Channel, 2022-2032, USD (Million)

14. Company Profile
14.1. Abbott Laboratories
14.1.1. Company Overview
14.1.2. Financial Performance
14.1.3. Product Portfolio
14.1.4. Strategic Initiatives
14.2. Allergan, Inc.
14.2.1. Company Overview
14.2.2. Financial Performance
14.2.3. Product Portfolio
14.2.4. Strategic Initiatives
14.3. AstraZeneca Plc
14.3.1. Company Overview
14.3.2. Financial Performance
14.3.3. Product Portfolio
14.3.4. Strategic Initiatives
14.4. Bayer AG
14.4.1. Company Overview
14.4.2. Financial Performance
14.4.3. Product Portfolio
14.4.4. Strategic Initiatives
14.5. Bristol-Myers Squibb Co.
14.5.1. Company Overview
14.5.2. Financial Performance
14.5.3. Product Portfolio
14.5.4. Strategic Initiatives
14.6. Eli Lilly and Company
14.6.1. Company Overview
14.6.2. Financial Performance
14.6.3. Product Portfolio
14.6.4. Strategic Initiatives
14.7. F. Hoffmann-La Roche Ltd.
14.7.1. Company Overview
14.7.2. Financial Performance
14.7.3. Product Portfolio
14.7.4. Strategic Initiatives
14.8. GlaxoSmithKline Plc
14.8.1. Company Overview
14.8.2. Financial Performance
14.8.3. Product Portfolio
14.8.4. Strategic Initiatives
14.9. Ionis Pharmaceuticals, Inc.
14.9.1. Company Overview
14.9.2. Financial Performance
14.9.3. Product Portfolio
14.9.4. Strategic Initiatives
14.10. Merck & Co., Inc.
14.10.1. Company Overview
14.10.2. Financial Performance
14.10.3. Product Portfolio
14.10.4. Strategic Initiatives
14.11. Novartis AG
14.11.1. Company Overview
14.11.2. Financial Performance
14.11.3. Product Portfolio
14.11.4. Strategic Initiatives
14.12. Pfizer, Inc.
14.12.1. Company Overview
14.12.2. Financial Performance
14.12.3. Product Portfolio
14.12.4. Strategic Initiatives
14.13. Teva Pharmaceutical Industries Ltd
14.13.1. Company Overview
14.13.2. Financial Performance
14.13.3. Product Portfolio
14.13.4. Strategic Initiatives
14.14. Other Notable Players
14.14.1. Company Overview
14.14.2. Financial Performance
14.14.3. Product Portfolio
14.14.4. Strategic Initiatives